Dark

Check out our Dark Pool Levels

BICX
BIOCORRX INC NEW
stock OTC

EOD

Jul 31, 2026

0.2600USD-13.333%(-0.0400)2,724

Pre-market

0.00USD-100.000%(-0.35)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 5, 2022

09:00AM EST BioCorRx to Present at the H.C. Wainwright BioConnect 2022 Conference GlobeNewswire Inc

Dec 9, 2021

09:00AM EST via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the Company), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced the appointment of Dr. Jie Shen to the Scientific Advisory Board (SAB). GlobeNewswire Inc

Nov 24, 2021

08:30AM EST BioCorRx to Participate in the Benzinga All Access Event on GlobeNewswire Inc

Nov 22, 2021

09:15AM EST Patent Application Covers Solid Implant Formulation for Drug Delivery GlobeNewswire Inc

Nov 16, 2021

09:23AM EST viaNewMediaWire --BioCorRx Inc. (OTCQB: BICX) (the Company), a developer and provider ofinnovative treatment programs for substance abuse and related disorders, today provided a business update for the third quarter ended September 30, 2021 and reported on recent corporate developments. GlobeNewswire Inc

Oct 7, 2021

08:30AM EDT BioCorRx Files Patent Application with the Russian Patent Office GlobeNewswire Inc

Oct 5, 2021

06:35AM EDT BICX: New Grant, Patent Filed Benzinga

Sep 29, 2021

12:17PM EDT BioCorRx to Present at LD Micro Main Event on Tuesday, October 12th GlobeNewswire Inc

Sep 22, 2021

08:30AM EDT BioCorRx Files Patent Application with USPTO for Naltrexone Implant GlobeNewswire Inc

Sep 8, 2021

07:00AM EDT Recro and BioCorRx Expand Development and Manufacturing GlobeNewswire Inc

Sep 1, 2021

08:30AM EDT BioCorRx Announces Award of Approximately $3.5 Million NIDA Grant GlobeNewswire Inc

Aug 16, 2021

08:30AM EDT viaNewMediaWire --BioCorRx Inc. (OTCQB: BICX) (the Company), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update for the second quarter ended June 30, 2021 and reported on recent corporate developments. GlobeNewswire Inc

Jun 22, 2021

08:30AM EDT BioCorRx Welcomes Four Experts to Expanded Scientific Advisory Board GlobeNewswire Inc

May 18, 2021

10:28AM EDT BICX: BICX104 IND Approved Benzinga

09:05AM EDT via NewMediaWire--BioCorRx Inc. (OTCQB: BICX) (BioCorRx or the Company), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update for the first quarter ended March 31, 2021 and reported on recent corporate developments. GlobeNewswire Inc

May 10, 2021

08:49AM EDT BioCorRx Says FDA Has Given Clearance To Proceed To Human Trials For BICX104 RTTNews

08:30AM EDT BioCorRx Receives FDA Clearance of Investigational New Drug (IND) GlobeNewswire Inc

Apr 13, 2021

08:00AM EDT BioCorRx Announces Submission of IND Application to the FDA for GlobeNewswire Inc

Apr 1, 2021

08:30AM EDT via NewMediaWire--BioCorRx Inc. (OTCQB: BICX) (the Company),a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a year-end business update for 2020 and reported on recent corporate developments. GlobeNewswire Inc

Mar 2, 2021

09:25AM EST BioCorRx Completes $2.25 Million Private Placement GlobeNewswire Inc

Feb 24, 2021

08:30AM EST via NewMediaWire--BioCorRx Inc. (OTCQB: BICX) (the Company),a developer and provider of advanced solutions in the treatment of substance use disorders, today announced that Joseph J. Galligan was appointed to the Companys Board of Directors. GlobeNewswire Inc

Jan 15, 2021

08:30AM EST BioCorRx Announces Update on NIDA Grant and Development of GlobeNewswire Inc

Nov 16, 2020

08:30AM EST Announces Promotion of Lourdes Felix to CEO; Brady Granier to Serve as President GlobeNewswire Inc

Oct 13, 2020

08:30AM EDT via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (BioCorRx) (Company), a developer and provider of advanced solutions in the treatment of substance use disorders (SUD), today announced their partnership withTruusight Health, a healthcare solutions and care navigation and management company, to bring the CompanysRecovery Programto self-funded health plans. GlobeNewswire Inc

Aug 14, 2020

08:30AM EDT via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the Company), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided a business update for the second quarter ended June 30, 2020. GlobeNewswire Inc

Share